AstraZeneca To Present 43 Abstracts At American Diabetes Association Sessions
LONDON (Alliance News) - Pharmaceuticals company AstraZeneca PLC Wednesday said that 43 abstracts reporting results of the company's research and development in diabetes have been accepted for presentation at the 74th Scientific Sessions of the American Diabetes Association in San Francisco next Read More